These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 18651551

  • 1. ORAMA: a study to investigate EBPG impact on renal anaemia - design and baseline data.
    Locatelli F, Covic A, Macdougall IC, Wiecek A, ORAMA Study Group.
    J Nephrol; 2008; 21(4):592-603. PubMed ID: 18651551
    [Abstract] [Full Text] [Related]

  • 2. Renal anemia: comparing current Eastern and Western European management practice (ORAMA).
    Wiecek A, Covic A, Locatelli F, Macdougall IC, ORAMA study group.
    Ren Fail; 2008; 30(3):267-76. PubMed ID: 18350446
    [Abstract] [Full Text] [Related]

  • 3. Effect of computer-assisted European Best Practice Guideline implementation on adherence and target attainment: ORAMA results.
    Locatelli F, Covic A, Macdougall IC, Scherhag A, Wiecek A, ORAMA Study Group.
    J Nephrol; 2009; 22(5):662-74. PubMed ID: 19810000
    [Abstract] [Full Text] [Related]

  • 4. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [Abstract] [Full Text] [Related]

  • 5. Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study.
    Ludwig H, Aapro M, Bokemeyer C, Macdonald K, Soubeyran P, Turner M, Albrecht T, Abraham I.
    Eur J Cancer; 2009 Jun; 45(9):1603-15. PubMed ID: 19278851
    [Abstract] [Full Text] [Related]

  • 6. Results of the European Survey on Anaemia Management 2003 (ESAM 2003): current status of anaemia management in dialysis patients, factors affecting epoetin dosage and changes in anaemia management over the last 5 years.
    Jacobs C, Frei D, Perkins AC.
    Nephrol Dial Transplant; 2005 May; 20 Suppl 3():iii3-24. PubMed ID: 15824128
    [Abstract] [Full Text] [Related]

  • 7. Effects of proactive iron and erythropoiesis-stimulating agent protocol implementation on achieving clinical guideline targets for anaemia in a satellite haemodialysis patient cohort.
    Yong K, Kairaitis L.
    Nephrology (Carlton); 2010 Apr; 15(3):288-93. PubMed ID: 20470296
    [Abstract] [Full Text] [Related]

  • 8. [Spanish survey on anaemia management].
    Pérez García R.
    Nefrologia; 2003 Apr; 23(4):300-11. PubMed ID: 14558329
    [Abstract] [Full Text] [Related]

  • 9. Is early treatment of anaemia with epoetin-alpha beneficial to pre-dialysis chronic kidney disease patients? Results of a multicentre, open-label, prospective, randomized, comparative group trial.
    Macdougall IC, Temple RM, Kwan JT.
    Nephrol Dial Transplant; 2007 Mar; 22(3):784-93. PubMed ID: 16968726
    [Abstract] [Full Text] [Related]

  • 10. Initiation of anaemia management in patients with chronic kidney disease not on dialysis in the Veterans Health Administration.
    Lawler EV, Gagnon DR, Fink J, Seliger S, Fonda J, Do TP, Gaziano JM, Bradbury BD.
    Nephrol Dial Transplant; 2010 Jul; 25(7):2237-44. PubMed ID: 20083469
    [Abstract] [Full Text] [Related]

  • 11. Optimal treatment of renal anaemia (OPTA): improving the efficacy and efficiency of renal anaemia therapy in haemodialysis patients receiving intravenous epoetin.
    Hörl WH, Vanrenterghem Y, Canaud B, Mann J, Teatini U, Wanner C, Wikström B.
    Nephrol Dial Transplant; 2005 May; 20 Suppl 3():iii25-32. PubMed ID: 15824127
    [Abstract] [Full Text] [Related]

  • 12. Prevalence and predictors of epoetin hyporesponsiveness in chronic kidney disease patients.
    Rossert J, Gassmann-Mayer C, Frei D, McClellan W.
    Nephrol Dial Transplant; 2007 Mar; 22(3):794-800. PubMed ID: 17210593
    [Abstract] [Full Text] [Related]

  • 13. Is it necessary to check outcomes to improve quality of care? The example of anemia management.
    Di Benedetto A, Richards N, Marcelli D, Basci A, Cesare S, Ponce P, Scatizzi L, Marotta P.
    J Nephrol; 2008 Mar; 21 Suppl 13():S146-52. PubMed ID: 18446749
    [Abstract] [Full Text] [Related]

  • 14. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.
    Mircescu G, Gârneata L, Capusa C, Ursea N.
    Nephrol Dial Transplant; 2006 Jan; 21(1):120-4. PubMed ID: 16144853
    [Abstract] [Full Text] [Related]

  • 15. Maintaining control over haemoglobin levels: optimizing the management of anaemia in chronic kidney disease.
    Bárány P, Müller HJ.
    Nephrol Dial Transplant; 2007 Jun; 22 Suppl 4():iv10-iv18. PubMed ID: 17526545
    [Abstract] [Full Text] [Related]

  • 16. Changes in hemoglobin level distribution in US dialysis patients from June 2006 to November 2008.
    Spiegel DM, Khan I, Krishnan M, Mayne TJ.
    Am J Kidney Dis; 2010 Jan; 55(1):113-20. PubMed ID: 19932539
    [Abstract] [Full Text] [Related]

  • 17. Changes in erythropoiesis-stimulating agent (ESA) dosing and haemoglobin levels in US non-dialysis chronic kidney disease patients between 2005 and 2009.
    Regidor D, McClellan WM, Kewalramani R, Sharma A, Bradbury BD.
    Nephrol Dial Transplant; 2011 May; 26(5):1583-91. PubMed ID: 20861195
    [Abstract] [Full Text] [Related]

  • 18. Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease.
    Carrero JJ, Bárány P, Yilmaz MI, Qureshi AR, Sonmez A, Heimbürger O, Ozgurtas T, Yenicesu M, Lindholm B, Stenvinkel P.
    Nephrol Dial Transplant; 2012 Feb; 27(2):709-15. PubMed ID: 21617198
    [Abstract] [Full Text] [Related]

  • 19. UK Renal Registry 16th annual report: chapter 10 haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2012: national and centre-specific analyses.
    Rao A, Gilg J, Williams A.
    Nephron Clin Pract; 2013 Feb; 125(1-4):183-208. PubMed ID: 24662174
    [Abstract] [Full Text] [Related]

  • 20. [Iron deficiency is a common cause of bad response to epoetin treatment. It's important to follow iron status--not only the Hb value].
    Wallerstedt SM, Ljungman S, Broms E, Andrén L.
    Lakartidningen; 2013 Feb; 102(37):2550-1, 2553-5. PubMed ID: 16200900
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.